This funding opportunity, sponsored by the National Institutes of Health (NIH), supports data mining of single cell data sets to identify cell types, transcripts, enhancers, or transcriptional networks integral to HIV/antiretroviral therapy (ART) or Substance Use Disorder (SUD) molecular responses. Additionally, it funds functional validation studies, such as epigenomic or transcriptomic manipulation and high throughput secondary screening, to confirm or refute the biological role of these identified molecular features in HIV/ART and SUD responses. Clinical trials are not allowed under this R01 funding mechanism.
This funding opportunity, sponsored by the National Institutes of Health (NIH), supports data mining of single cell data sets to identify cell types, transcripts, enhancers, or transcriptional networks integral to HIV/antiretroviral therapy (ART) or Substance Use Disorder (SUD) molecular responses. Additionally, it funds functional validation studies, such as epigenomic or transcriptomic manipulation and high throughput secondary screening, to confirm or refute the biological role of these identified molecular features in HIV/ART and SUD responses. Clinical trials are not allowed under this R01 funding mechanism.